Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1276666-10-4

Post Buying Request

1276666-10-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Factory direct supply N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate with best quality

    Cas No: 1276666-10-4

  • USD $ 90.0-100.0 / Kilogram

  • 1 Kilogram

  • 10 Metric Ton/Day

  • Toda Biotechnology Co., Limited.
  • Contact Supplier

1276666-10-4 Usage

General Description

Tert-butyl 2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)amino)ethylcarbamate is a complex chemical compound with a molecular structure that includes a tert-butyl functional group, a 5-chlorobenzo[d]oxazol-2-yl group, and a 3-oxobutylamino group. tert-butyl 2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)amino)ethylcarbamate is an ethylcarbamate derivative, which is a type of organic compound that contains a carbamate functional group. Ethylcarbamates are used in various chemical and pharmaceutical applications, including as intermediates in the synthesis of other compounds and as potential pharmacological agents. The specific properties and uses of tert-butyl 2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)amino)ethylcarbamate would depend on its exact chemical composition and structure, and further research would be necessary to fully understand its potential applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1276666-10-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,7,6,6,6 and 6 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1276666-10:
(9*1)+(8*2)+(7*7)+(6*6)+(5*6)+(4*6)+(3*6)+(2*1)+(1*0)=184
184 % 10 = 4
So 1276666-10-4 is a valid CAS Registry Number.

1276666-10-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate

1.2 Other means of identification

Product number -
Other names tert-Butyl 2-((5-chlorobenzo[d]oxazol-2-yl)(3-oxobutyl)amino)ethylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1276666-10-4 SDS

1276666-10-4Relevant articles and documents

A [2 - [(5 - chloro - benzo oxazole - 2 - yl) (3 - oxo-butyl) amino] ethyl] carbamic acid tert-butyl preparation method (by machine translation)

-

, (2017/04/19)

The invention discloses a [2 - [(5 - chloro - benzo oxazole - 2 - yl) (3 - oxo-butyl) amino] ethyl] carbamic acid tert-butyl preparation method, in order to ethylenediamine, vinyl, 2 - amino - 4 - chlorophenol and the like as raw materials, after five-step reaction to obtain the target product [2 - [(5 - chloro - benzo oxazole - 2 - yl) (3 - oxo-butyl) amino] ethyl] tert-butyl carbamate. The invention has simple operation, environment friendly, comprehensive yield is 52% more, than the existing 35.6% yield, with a remarkable enhancement, greatly reduces the production cost of the existing drugs, is suitable for industrial scale production. (by machine translation)

Process for the preparation of an intermediate for an orexin receptor antagonist

-

Page/Page column 9; 10, (2017/02/02)

The present invention is directed to processes for preparing an intermediate for a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved.

PROCESS FOR THE PREPARATION OF AN OREXIN RECEPTOR ANTAGONIST

-

Page/Page column 38-39, (2012/11/13)

The present invention is directed to processes for preparing a diazepane compound which is an antagonist of orexin receptors, and which is useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is further directed to crystalline forms of this diazepane compound and pharmaceutical compositions thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1276666-10-4